Drug Induced Interstitial Lung Disease (DIILD) Cancer Patients Clinical Trial
Official title:
Qualification of Imaging Methods to Assess Cancer Drug Induced Interstitial Lung Disease (ImageILD)
Drug induced interstitial lung disease (DIILD) is caused by iatrogenic injury to the lung
parenchyma and can be caused by over four hundred different drugs in humans. Diagnosing DIILD
is a challenge for clinicians and radiologists as a positive diagnosis depends on exclusion
of other causes including respiratory infection, occupational, recreational, and
environmental exposures, specific respiratory disorders, and systemic diseases.
The aim of this study is to qualify an objective CT scoring system for DIILD assessment. In
addition, the quantitative information obtained from CT scans with densitometry and texture
analysis will be explored.
n/a